Coagulation Analyzer Aids Management of Warfarin
By HospiMedica International staff writers Posted on 26 May 2015 |
A hand-held coagulation analyzer enables rapid decision-making in physician offices and clinics monitoring patient oral anticoagulation therapy (OAT).
The Xprecia Stride Coagulation Analyzer is a portable device that delivers fast, reliable prothrombin time (PT) results and the international normalized ratio (INR) measure for point-of-care monitoring and management of OAT with warfarin, a vitamin K antagonist. The new analyzer was specifically designed to meet the growing demand for fast and reliable point of care (POC) PT/INR results needed by healthcare professionals to make informed decisions. The device uses fresh capillary (finger stick) whole blood, utilizing the same reagent used by central lab analyzers to minimize any potential for variability.
To help increase workflow efficiency and usability, an integrated bar-code scanner checks calibration data of new lot numbers prior to testing. Safety features include a spring-loaded test strip eject button that allows users to eject a used test strip and dispose of it without touching it, minimizing potential biohazard exposure. Other features include easy data transfer to a computer and a color display with animated step-by-step instructions to help guide the user during testing. The Xprecia Stride Coagulation Analyzer is a product of Siemens Healthcare Diagnostics (Tarrytown, NY, USA).
“The Xprecia Stride Coagulation Analyzer is among the most radical, user-friendly redesigns of a point-of-care coagulation analyzer since they became widely available more than 20 years ago,” said David Stein, PhD, CEO of the Siemens Diagnostics point of care business unit. “The Xprecia Stride Analyzer uses simple icons and animation in a color display more commonly found in smartphones than medical instruments.”
“Unlike our previous coagulation point-of-care analyzer, the Xprecia Stride analyzer does not place any limits on us as to the kinds of patients that can be tested,” said hematologist Maria Labrador, MD, of Hospital Cruz Roja (Cordoba, Spain). “We test around 50 patients a day for PT/INR using the Xprecia Stride analyzer and we have been happy with the results from the very beginning.”
Warfarin decreases blood coagulation by inhibiting vitamin K epoxide reductase, an enzyme that recycles oxidized vitamin K to its reduced form after it has participated in the carboxylation of several blood coagulation proteins, mainly prothrombin and factor VII. It was initially introduced in 1948 as a pesticide against rats and mice and is still popular for this purpose. In the early 1950's warfarin was found to be effective and relatively safe for preventing thrombosis and embolism in many disorders. It is the most widely prescribed oral anticoagulant drug in North America.
Related Links:
Siemens Healthcare Diagnostics
Hospital Cruz Roja
The Xprecia Stride Coagulation Analyzer is a portable device that delivers fast, reliable prothrombin time (PT) results and the international normalized ratio (INR) measure for point-of-care monitoring and management of OAT with warfarin, a vitamin K antagonist. The new analyzer was specifically designed to meet the growing demand for fast and reliable point of care (POC) PT/INR results needed by healthcare professionals to make informed decisions. The device uses fresh capillary (finger stick) whole blood, utilizing the same reagent used by central lab analyzers to minimize any potential for variability.
To help increase workflow efficiency and usability, an integrated bar-code scanner checks calibration data of new lot numbers prior to testing. Safety features include a spring-loaded test strip eject button that allows users to eject a used test strip and dispose of it without touching it, minimizing potential biohazard exposure. Other features include easy data transfer to a computer and a color display with animated step-by-step instructions to help guide the user during testing. The Xprecia Stride Coagulation Analyzer is a product of Siemens Healthcare Diagnostics (Tarrytown, NY, USA).
“The Xprecia Stride Coagulation Analyzer is among the most radical, user-friendly redesigns of a point-of-care coagulation analyzer since they became widely available more than 20 years ago,” said David Stein, PhD, CEO of the Siemens Diagnostics point of care business unit. “The Xprecia Stride Analyzer uses simple icons and animation in a color display more commonly found in smartphones than medical instruments.”
“Unlike our previous coagulation point-of-care analyzer, the Xprecia Stride analyzer does not place any limits on us as to the kinds of patients that can be tested,” said hematologist Maria Labrador, MD, of Hospital Cruz Roja (Cordoba, Spain). “We test around 50 patients a day for PT/INR using the Xprecia Stride analyzer and we have been happy with the results from the very beginning.”
Warfarin decreases blood coagulation by inhibiting vitamin K epoxide reductase, an enzyme that recycles oxidized vitamin K to its reduced form after it has participated in the carboxylation of several blood coagulation proteins, mainly prothrombin and factor VII. It was initially introduced in 1948 as a pesticide against rats and mice and is still popular for this purpose. In the early 1950's warfarin was found to be effective and relatively safe for preventing thrombosis and embolism in many disorders. It is the most widely prescribed oral anticoagulant drug in North America.
Related Links:
Siemens Healthcare Diagnostics
Hospital Cruz Roja
Read the full article by registering today, it's FREE!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
- Free digital version edition of HospiMedica International sent by email on regular basis
- Free print version of HospiMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of HospiMedica International in digital format
- Free HospiMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest Critical Care News
- Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients
- Peptide-Based Hydrogels Repair Damaged Organs and Tissues On-The-Spot
- One-Hour Endoscopic Procedure Could Eliminate Need for Insulin for Type 2 Diabetes
- AI Can Prioritize Emergency Department Patients Requiring Urgent Treatment
- AI to Improve Diagnosis of Atrial Fibrillation
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure